Condition
Metastatic Bladder Urothelial Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Metastatic Bladder Urothelial Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Metastatic Bladder Urothelial Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Therapeutic plasma exchange plus enfortumab vedotin and pembrolizumab for bladder and upper urinary tract urothelial cancer | Phase 2 | Rochester, Minnesota | Recruiting | Jul 28, 2025 |
| Combination of Enfortumab Vedotin and Pembrolizumab with Surgery for Advanced Bladder Cancer | Phase 4 | Rochester, Minnesota | Recruiting | Jan 8, 2025 |
| Using pemetrexed to treat metastatic bladder cancer and other solid tumors with specific gene mutations | Phase 2 | Chicago, Illinois and 1 other locations | Recruiting | Oct 8, 2024 |
| Predicting how tumors respond to immune therapies using a live diagnostic platform | — | Phoenix, Arizona and 2 other locations | Recruiting | Apr 5, 2024 |
All recruiting trials (4)
-
Therapeutic plasma exchange plus enfortumab vedotin and pembrolizumab for bladder and upper urinary tract urothelial cancer
This trial will test whether doing a therapeutic plasma exchange before giving enfortumab vedotin (an antibody‑drug conjugate) and pembrolizumab (an immune checkpoint inhibitor) helps people with metastatic or refractory urothelial (bladder or upper tract) cancer who have progressed on prior therapies.
-
Combination of Enfortumab Vedotin and Pembrolizumab with Surgery for Advanced Bladder Cancer
This study is testing if a combination of two medications, enfortumab vedotin and pembrolizumab, can help people with advanced bladder cancer before they have surgery.
-
Using pemetrexed to treat metastatic bladder cancer and other solid tumors with specific gene mutations
This study is testing if the drug pemetrexed can help people with advanced bladder cancer and other solid tumors that have certain gene mutations.
-
Predicting how tumors respond to immune therapies using a live diagnostic platform
This study is testing a new way to predict how well immune therapies will work for patients with different types of solid tumors, including early-stage and metastatic cancers.
Related topics
Quick answers
How many Metastatic Bladder Urothelial Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.